SDHC and paraganglioma: Based on the totality of this evidence, the germline SDHC:c.374T>G variant, previously classified as VUS by the clinical laboratory, was classified as presumed deleterious and treated as a clinically significant finding in relation to hereditary paraganglioma in this patient.